These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 1652330)

  • 1. CMV prophylaxis in allogeneic BMT with ganciclovir and CMV immune globulin.
    Patton WN; Carter C; Bienz N; Lamb T; Boughton BJ; Franklin IM
    Bone Marrow Transplant; 1991; 7 Suppl 2():44. PubMed ID: 1652330
    [No Abstract]   [Full Text] [Related]  

  • 2. Prevention of early interstitial pneumonitis (IP) after BMT by exclusion of CMV-IG-POS platelet donors, prophylaxis with CMV immune globuline, and by a modified TBI regimen.
    Hinterberger W; Alth G; Höcker P; Kallinger W; Kier P; Kolbabek H; Lechner K; Popov-Kraup T
    Bone Marrow Transplant; 1991; 7 Suppl 2():43. PubMed ID: 1652329
    [No Abstract]   [Full Text] [Related]  

  • 3. Immune globulin therapy in allogeneic bone marrow transplant: a critical review.
    Guglielmo BJ; Wong-Beringer A; Linker CA
    Bone Marrow Transplant; 1994 May; 13(5):499-510. PubMed ID: 8054903
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of severe cytomegalovirus infection with ganciclovir and high-dose intravenous immunoglobulin in patients with allogeneic bone marrow transplants. A pilot study.
    Lehn P; Quessar A; Devergie A; Esperou-Bourdeau H; Traineau R; Trédaniel J; Benbunan M; Bussel A; Jolivet I; Mazeron MC
    Nouv Rev Fr Hematol (1978); 1990; 32(1):17-20. PubMed ID: 2161510
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Should all CMV infections after bone marrow transplantation be treated?
    Jouet JP; Draoui A; Facon T; Noel-Walter MP; Wattre P; Fenaux P; Dupriez B; Morel P; Bauters F
    Bone Marrow Transplant; 1991; 7 Suppl 2():47. PubMed ID: 1652333
    [No Abstract]   [Full Text] [Related]  

  • 6. Comparison of cytomegalovirus antigenemia and shell vial culture in allogeneic marrow transplantation recipients receiving ganciclovir prophylaxis.
    Nicholson VA; Whimbey E; Champlin R; Abi-Said D; Przepiorka D; Tarrand J; Chan K; Bodey GP; Goodrich JM
    Bone Marrow Transplant; 1997 Jan; 19(1):37-41. PubMed ID: 9012929
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ganciclovir and the prevention of CMV disease after allogeneic BMT: policy at the Hammersmith Hospital.
    Ward KN; Roberts IA; van Rhee F
    Bone Marrow Transplant; 1994 Feb; 13(2):230-1. PubMed ID: 8205098
    [No Abstract]   [Full Text] [Related]  

  • 8. A randomised trial comparing cytomegalovirus antigenemia assay vs screening bronchoscopy for the early detection and prevention of disease in allogeneic bone marrow and peripheral blood stem cell transplant recipients.
    Humar A; Lipton J; Welsh S; Moussa G; Messner H; Mazzulli T
    Bone Marrow Transplant; 2001 Sep; 28(5):485-90. PubMed ID: 11593322
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pre-emptive ganciclovir treatment can play a role in restoration of hematopoiesis after allogeneic bone marrow transplantation.
    Choi JH; Kim DW; Cho SG; Yoo JH; Jeong DC; Han CW; Shin WS; Min WS; Kim HK; Kim CC; Kim DJ
    Bone Marrow Transplant; 1997 Jan; 19(2):187-90. PubMed ID: 9116619
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intravenous hyperimmune globulin prophylaxis against cytomegalovirus interstitial pneumonitis after allogenic bone marrow transplantation.
    Jacobsen N; Schäfer U; Ostendorf P; Kubaneck B; Wolf H
    Tokai J Exp Clin Med; 1985 Jun; 10(2-3):193-5. PubMed ID: 3010510
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prophylactic use of ganciclovir for allogeneic bone marrow transplant recipients.
    von Bueltzingsloewen A; Bordigoni P; Witz F; Bene MC; Schmitt C; Lacour B; Sommelet D
    Bone Marrow Transplant; 1993 Sep; 12(3):197-202. PubMed ID: 8241976
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Randomized clinical trial of ganciclovir vs acyclovir for prevention of cytomegalovirus antigenemia after allogeneic transplantation.
    Burns LJ; Miller W; Kandaswamy C; DeFor TE; MacMillan ML; Van Burik JA; Weisdorf DJ
    Bone Marrow Transplant; 2002 Dec; 30(12):945-51. PubMed ID: 12476289
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ganciclovir prophylaxis for cytomegalovirus infection in pediatric allogeneic bone marrow transplant recipients.
    Canpolat C; Culbert S; Gardner M; Whimbey E; Tarrand J; Chan KW
    Bone Marrow Transplant; 1996 Apr; 17(4):589-93. PubMed ID: 8722360
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Prophylaxis and treatment of cytomegalovirus infection in allogeneic bone marrow transplantation].
    Guo N; Lu D; Liu D
    Zhonghua Xue Ye Xue Za Zhi; 1999 Aug; 20(8):402-4. PubMed ID: 11721418
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytomegalovirus surveillance and prevention in allogeneic bone marrow transplantation: examination of a preemptive plan of ganciclovir therapy.
    Mandanas RA; Saez RA; Selby GB; Confer DL
    Am J Hematol; 1996 Feb; 51(2):104-11. PubMed ID: 8579049
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A survey of allogeneic bone marrow transplant programs in the United States regarding cytomegalovirus prophylaxis and pre-emptive therapy.
    Avery RK; Adal KA; Longworth DL; Bolwell BJ
    Bone Marrow Transplant; 2000 Oct; 26(7):763-7. PubMed ID: 11042658
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rapid detection of CMV reactivation after BMT by CMV-IEA expression in granulocytes.
    Boland GJ; Vlieger A; de Gast GC; Zwaan FE; Verdonck LF; de Weger RA; Jiwa NM
    Bone Marrow Transplant; 1991; 7 Suppl 2():42. PubMed ID: 1652328
    [No Abstract]   [Full Text] [Related]  

  • 18. Use of a semi-quantitative PCR for cytomegalovirus DNA as a basis for pre-emptive antiviral therapy in allogeneic bone marrow transplant patients.
    Ljungman P; Loré K; Aschan J; Klaesson S; Lewensohn-Fuchs I; Lönnqvist B; Ringdén O; Winiarski J; Ehrnst A
    Bone Marrow Transplant; 1996 Apr; 17(4):583-7. PubMed ID: 8722359
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Prevention of cytomegalovirus infection and disease in the transplantation patient].
    Cisneros JM; Pachón J
    Enferm Infecc Microbiol Clin; 1993 Jan; 11(1):40-4. PubMed ID: 8384888
    [No Abstract]   [Full Text] [Related]  

  • 20. Progress in the prevention of cytomegalovirus infection after allogeneic bone marrow transplantation.
    Devergie A; Traineau R; Esperou-Bourdeau H; Ribaud P; Socié G; Richard P; Selimi F; Hirsch I; Gluckman E
    Nouv Rev Fr Hematol (1978); 1994; 36 Suppl 1():S89-90. PubMed ID: 8177726
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.